Literature DB >> 23161806

UHPLC/ESI-Q-TOF-MS method for the measurement of dopamine in rodent striatal tissue: a comparative effects of intranasal administration of ropinirole solution over nanoemulsion.

Gulam Mustafa1, Niyaz Ahmad, Sanjula Baboota, Javed Ali, Alka Ahuja.   

Abstract

An ultra high performance liquid chromatography-electrospray ionization-tandem mass spectrometric method (UHPLC/ESI-Q-TOF-MS) for the analysis of dopamine (DA) in Wistar rat brain homogenate has been developed and validated. The chromatographic separation was achieved on a Waters ACQUITY UPLC™ BEH C18 (100.0 mm × 2.1 mm; 1.7 µm) column using isocratic mobile phase, consisting of acetonitrile and Formic acid (0.1% w/v) (10: 90; v/v), at a flow rate of 0.15 ml min(-1) . The transitions occurred at m/z 154.04 → 137.006 for DA, and m/z 184.204 → 166.08 for the internal standard. The recovery of the analytes from Wistar rat brain homogenate was optimized using liquid-liquid extraction technique (LLE) in ethyl acetate. The total run time was 3.5 min and the elution of DA occurred at 1.44 ± 0.05 min. The linear dynamic range was established over the concentration range 75-750 ng mL(-1) (r(2) ; 0.9921 ± 0.0005) for DA. The intra-assay and inter-assay accuracy in terms of % CV was in the range 0.73-2.80. The lower limit of detection (LOD) and quantitation (LOQ) for DA was 0.278 and 0.844 ng mL(-1) , respectively. Analytes were stable under various conditions (in autosampler, during freeze-thaw, at room temperature, and under deep-freeze conditions). The developed method was successfully applied for in vivo profiling in rodents.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Parkinson's disease; UHPLC/ESI-Q-TOF-MS; dopamine; ex vivo stability; matrix effect; ruggedness; validation

Mesh:

Substances:

Year:  2012        PMID: 23161806     DOI: 10.1002/dta.1426

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  3 in total

1.  Quantification of rutin in rat's brain by UHPLC/ESI-Q-TOF-MS/MS after intranasal administration of rutin loaded chitosan nanoparticles.

Authors:  Niyaz Ahmad; Rizwan Ahmad; Atta Abbas Naqvi; Md Aftab Alam; Mohd Samim; Zeenat Iqbal; Farhan Jalees Ahmad
Journal:  EXCLI J       Date:  2016-08-17       Impact factor: 4.068

2.  Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles.

Authors:  Niyaz Ahmad; Rizwan Ahmad; Md Aftab Alam; Farhan Jalees Ahmad
Journal:  Chem Cent J       Date:  2018-05-23       Impact factor: 4.215

3.  Brain targeting stealth lipomers of combined antiepileptic-anti-inflammatory drugs as alternative therapy for conventional anti-Parkinson's.

Authors:  Iman M Higazy
Journal:  Saudi Pharm J       Date:  2019-11-13       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.